Billing, Coding & Reimbursement
Reference tables for CPT procedure codes, ICD-10 diagnosis codes, and billing modifiers relevant to functional urology, GU reconstruction, and female pelvic medicine. Code descriptions are paraphrased and wRVU values are for educational reference. wRVUs are Medicare Physician Fee Schedule work RVUs from the CMS CY2026 relative value file (RVU26C, July 2026 release). The CY2026 conversion factor is $33.4009 ($33.5675 for clinicians who are qualifying APM participants). Values change each January, and "Carrier priced" codes have no national wRVU. Verify against the AMA CPT database and the CMS Physician Fee Schedule before billing.
Note on terminology. Several ICD-10 code descriptions below (e.g., F64.0 Transsexualism, Q56.0–Q56.4 Hermaphroditism / Pseudohermaphroditism, Z87.890 Personal history of sex reassignment) use clinical language that is now outdated and, in some cases, considered stigmatizing. The text is reproduced verbatim from the WHO/CMS code set because billing accuracy requires matching the official descriptor. In clinical documentation and patient-facing communication, use current terminology (e.g., differences of sex development (DSD), gender dysphoria or gender incongruence, gender-affirming surgery).
- CPT Procedure Codes
- ICD-10 Diagnosis Codes
- Modifiers
- External Coding Resources
| CPT | Procedure Name | Type | wRVUs |
|---|---|---|---|
| 53444 | Insertion of tandem cuff (second cuff) artificial urinary sphincter | AUS | 13.84 |
| 53445 | Insertion of artificial urinary sphincter (bladder neck or urethra), all components | AUS | 12.68 |
| 53446 | Removal of artificial urinary sphincter (bladder neck or urethra), all components | AUS | 10.74 |
| 53447 | Removal and replacement of artificial urinary sphincter, all components | AUS | 13.92 |
| 53448 | Removal and replacement of artificial urinary sphincter, all components, infected field | AUS | 22.85 |
| 53449 | Repair of artificial urinary sphincter: cuff, pump, or reservoir | AUS | 10.30 |
| 54400 | Insertion of penile prosthesis; non-inflatable (malleable) | Penile Prosthesis | 8.94 |
| 54405 | Insertion of multi-component, inflatable penile prosthesis (3-piece IPP) | Penile Prosthesis | 14.16 |
| 54406 | Removal of all components of inflatable penile prosthesis without replacement | Penile Prosthesis | 12.57 |
| 54408 | Repair of component(s) of multi-component inflatable penile prosthesis | Penile Prosthesis | 13.56 |
| 54410 | Removal and replacement of all components of multi-component IPP (non-infected) | Penile Prosthesis | 14.80 |
| 54411 | Removal and replacement of all components of multi-component IPP (infected field) | Penile Prosthesis | 17.89 |
| 54415 | Removal of non-inflatable (malleable) penile prosthesis without replacement | Penile Prosthesis | 8.66 |
| 54416 | Removal and replacement of non-inflatable (malleable) penile prosthesis | Penile Prosthesis | 11.78 |
| 54417 | Removal and replacement of non-inflatable (malleable) penile prosthesis (infected field) | Penile Prosthesis | 15.70 |
| 54110 | Incision of penile plaque (Peyronie's disease) | Peyronie's | 10.92 |
| 54111 | Incision of penile plaque (Peyronie's); with grafting 5 cm or less | Peyronie's | 14.42 |
| 54112 | Incision of penile plaque (Peyronie's); with graft greater than 5 cm | Peyronie's | 16.98 |
| 54200 | Injection procedure for Peyronie's disease (e.g., collagenase) | Peyronie's | 1.11 |
| 54205 | Injection procedure for Peyronie's with surgical exposure of plaque | Peyronie's | 8.97 |
| 54360 | Plastic operation on penis to correct angulation | Peyronie's | 11.44 |
| 53400 | Urethroplasty; first stage, for fistula, diverticulum, or stricture (e.g., Johanson) | Urethroplasty | 13.78 |
| 53405 | Urethroplasty; second stage (formation of urethra), including urinary diversion | Urethroplasty | 15.27 |
| 53410 | Urethroplasty, 1-stage reconstruction of male anterior urethra | Urethroplasty | 17.24 |
| 53415 | Urethroplasty, transpubic or perineal, 1-stage, prostatic or membranous urethra | Urethroplasty | 20.18 |
| 53420 | Urethroplasty, 2-stage reconstruction or repair of prostatic or membranous urethra; first stage | Urethroplasty | 14.79 |
| 53425 | Urethroplasty, 2-stage; second stage | Urethroplasty | 16.64 |
| 53430 | Urethroplasty, reconstruction of female urethra | Urethroplasty | 16.99 |
| 53431 | Urethroplasty with tubularization of posterior urethra and/or lower bladder for incontinence (e.g., Tenago) | Urethroplasty | 20.65 |
| 53450 | Urethromeatoplasty, with mucosal advancement | Urethroplasty | 6.60 |
| 53460 | Urethromeatoplasty, with partial excision of distal urethral segment (Richardson) | Urethroplasty | 7.56 |
| 53520 | Closure of urethrostomy or urethrocutaneous fistula, male | Urethroplasty | 9.24 |
| 52275 | Cystourethroscopy with internal urethrotomy, male | Bladder Neck | 4.57 |
| 52276 | Cystourethroscopy with direct vision internal urethrotomy | Bladder Neck | 4.87 |
| 52277 | Cystourethroscopy with resection of external sphincter (sphincterotomy) | Bladder Neck | 6.01 |
| 52450 | Transurethral incision of prostate (TUIP) — applicable to bladder-neck contracture | Bladder Neck | 7.59 |
| 52640 | Transurethral resection or incision of postoperative bladder neck contracture (TUIBNC) | Bladder Neck | 4.67 |
| 53860 | Transurethral radiofrequency micro-remodeling of female bladder neck and urethra (SUI) | Bladder Neck | 3.87 |
| 51840 | Anterior vesicourethropexy (e.g., Marshall-Marchetti-Krantz), simple | Sling / SUI | 11.08 |
| 51841 | Anterior vesicourethropexy; complicated (e.g., secondary repair) | Sling / SUI | 13.34 |
| 51845 | Abdomino-vaginal vesical neck suspension (e.g., Stamey, Raz, modified Pereyra) | Sling / SUI | 9.90 |
| 51990 | Laparoscopic urethral suspension for stress incontinence | Sling / SUI | 13.03 |
| 51992 | Laparoscopic sling operation for stress incontinence (e.g., fascia or synthetic) | Sling / SUI | 14.50 |
| 53442 | Removal or revision of sling for male urinary incontinence | Sling / SUI | 13.15 |
| 57288 | Sling operation for stress incontinence (e.g., fascia or synthetic) | Sling / SUI | 11.83 |
| 51715 | Endoscopic injection of implant material into submucosal tissues of urethra/bladder neck (urethral bulking) | Urethra Other | 3.64 |
| 53230 | Excision of urethral diverticulum (separate procedure); female | Urethra Other | 10.18 |
| 53235 | Excision of urethral diverticulum; male | Urethra Other | 10.72 |
| 53240 | Marsupialization of urethral diverticulum, male or female | Urethra Other | 6.90 |
| 51900 | Closure of vesicovaginal fistula, abdominal approach | Fistula Repair | 14.26 |
| 51920 | Closure of vesicouterine fistula | Fistula Repair | 13.07 |
| 51925 | Closure of vesicouterine fistula with hysterectomy | Fistula Repair | 17.09 |
| 57300 | Closure of rectovaginal fistula; vaginal or perineal approach | Fistula Repair | 8.49 |
| 57305 | Closure of rectovaginal fistula with synchronous colostomy | Fistula Repair | 14.97 |
| 57307 | Closure of rectovaginal fistula with abdominal approach and/or revision of colostomy | Fistula Repair | 16.74 |
| 57308 | Closure of rectovaginal fistula; transperineal approach with perineal body reconstruction | Fistula Repair | 10.33 |
| 57310 | Closure of urethrovaginal fistula | Fistula Repair | 7.46 |
| 57311 | Closure of urethrovaginal fistula; with bulbocavernosus transplant | Fistula Repair | 8.69 |
| 57320 | Closure of vesicovaginal fistula; vaginal approach | Fistula Repair | 8.66 |
| 57330 | Closure of vesicovaginal fistula; transvesical and vaginal approach | Fistula Repair | 12.88 |
| 45800 | Closure of rectovesical fistula (rectourethral) | Fistula Repair | 19.80 |
| 45805 | Closure of rectovesical fistula with colostomy | Fistula Repair | 22.74 |
| 51725 | Simple cystometrography (e.g., spinal manometer) | Urodynamics | 1.47 |
| 51726 | Complex cystometrography (with or without voiding pressure or urethral pressure profile) | Urodynamics | 1.67 |
| 51727 | Complex cystometrography with urethral pressure profile | Urodynamics | 2.06 |
| 51728 | Complex cystometrography with voiding pressure studies | Urodynamics | 2.06 |
| 51729 | Complex cystometrography with voiding pressure studies and urethral pressure profile | Urodynamics | 2.45 |
| 51736 | Simple uroflowmetry (e.g., stop-watch flow rate, mechanical uroflow) | Urodynamics | 0.17 |
| 51741 | Complex uroflowmetry (e.g., calibrated electronic equipment) | Urodynamics | 0.17 |
| 51784 | Electromyography studies of anal or urethral sphincter, other than needle | Urodynamics | 0.73 |
| 51785 | Needle electromyography studies of anal or urethral sphincter, any technique | Urodynamics | 1.49 |
| 51792 | Stimulus evoked response (e.g., bulbocavernosus reflex latency) | Urodynamics | 1.07 |
| 51797 | Voiding pressure studies, intra-abdominal (rectal, gastric, intraperitoneal) | Urodynamics | 0.78 |
| 51798 | Measurement of post-void residual urine and/or bladder capacity by ultrasound | Urodynamics | 0.00 |
| 58150 | Total abdominal hysterectomy (corpus and cervix), with/without removal of tube(s)/ovary(s) | Hysterectomy | 16.88 |
| 58152 | Total abdominal hysterectomy with colpo-urethropexy | Hysterectomy | 21.31 |
| 58180 | Supracervical abdominal hysterectomy (subtotal) | Hysterectomy | 16.19 |
| 58200 | Total abdominal hysterectomy including partial vaginectomy; with para-aortic and pelvic lymph node sampling | Hysterectomy | 22.52 |
| 58260 | Vaginal hysterectomy, for uterus 250 g or less | Hysterectomy | 13.80 |
| 58262 | Vaginal hysterectomy, ≤250 g; with removal of tube(s) and/or ovary(s) | Hysterectomy | 15.54 |
| 58263 | Vaginal hysterectomy, ≤250 g; with adnexectomy and enterocele repair | Hysterectomy | 16.80 |
| 58267 | Vaginal hysterectomy, ≤250 g; with anterior and/or posterior colporrhaphy | Hysterectomy | 17.90 |
| 58270 | Vaginal hysterectomy, ≤250 g; with repair of enterocele | Hysterectomy | 14.92 |
| 58290 | Vaginal hysterectomy, >250 g | Hysterectomy | 19.76 |
| 58291 | Vaginal hysterectomy, >250 g; with adnexectomy | Hysterectomy | 21.51 |
| 58292 | Vaginal hysterectomy, >250 g; with adnexectomy and enterocele repair | Hysterectomy | 22.77 |
| 58293 | Vaginal hysterectomy, >250 g; with colporrhaphy | Hysterectomy | Not on CY2026 PFS |
| 58294 | Vaginal hysterectomy, >250 g; with repair of enterocele | Hysterectomy | 21.01 |
| 58541 | Laparoscopic supracervical hysterectomy, ≤250 g | Hysterectomy | 11.98 |
| 58542 | Laparoscopic supracervical hysterectomy, ≤250 g; with adnexectomy | Hysterectomy | 13.81 |
| 58543 | Laparoscopic supracervical hysterectomy, >250 g | Hysterectomy | 14.03 |
| 58544 | Laparoscopic supracervical hysterectomy, >250 g; with adnexectomy | Hysterectomy | 15.21 |
| 58550 | Laparoscopic-assisted vaginal hysterectomy (LAVH), ≤250 g | Hysterectomy | 14.72 |
| 58552 | LAVH, ≤250 g; with adnexectomy | Hysterectomy | 16.49 |
| 58553 | LAVH, >250 g | Hysterectomy | 19.56 |
| 58554 | LAVH, >250 g; with adnexectomy | Hysterectomy | 22.53 |
| 58570 | Laparoscopic total hysterectomy, ≤250 g | Hysterectomy | 13.03 |
| 58571 | Laparoscopic total hysterectomy, ≤250 g; with adnexectomy | Hysterectomy | 14.63 |
| 58572 | Laparoscopic total hysterectomy, >250 g | Hysterectomy | 17.27 |
| 58573 | Laparoscopic total hysterectomy, >250 g; with adnexectomy | Hysterectomy | 20.27 |
| 56810 | Perineoplasty, repair of perineum, nonobstetrical | Prolapse Repair | 4.18 |
| 57106 | Vaginectomy, partial removal of vaginal wall | Prolapse Repair | 7.31 |
| 57110 | Vaginectomy, complete removal of vaginal wall | Prolapse Repair | 15.09 |
| 57120 | Colpocleisis (Le Fort type) | Prolapse Repair | 8.07 |
| 57200 | Colporrhaphy, suture of injury of vagina (nonobstetrical) | Prolapse Repair | 4.31 |
| 57210 | Colporrhaphy, with extension to perineum | Prolapse Repair | 5.57 |
| 57220 | Plastic operation on urethral sphincter, vaginal approach (Kelly plication) | Prolapse Repair | 4.73 |
| 57230 | Plastic repair of urethrocele | Prolapse Repair | 6.14 |
| 57240 | Anterior colporrhaphy, repair of cystocele with or without urethrocele, includes cystoscopy | Prolapse Repair | 9.83 |
| 57250 | Posterior colporrhaphy, repair of rectocele with or without perineorrhaphy | Prolapse Repair | 9.83 |
| 57260 | Combined anteroposterior colporrhaphy | Prolapse Repair | 12.92 |
| 57265 | Combined anteroposterior colporrhaphy with enterocele repair | Prolapse Repair | 14.63 |
| 57267 | Insertion of mesh or other prosthesis for repair of pelvic floor defect, each site (add-on) | Prolapse Repair | 4.76 |
| 57268 | Repair of enterocele, vaginal approach (separate procedure) | Prolapse Repair | 7.38 |
| 57270 | Repair of enterocele, abdominal approach (separate procedure) | Prolapse Repair | 13.33 |
| 57280 | Colpopexy, abdominal approach (open sacrocolpopexy) | Prolapse Repair | 16.30 |
| 57282 | Colpopexy, vaginal extraperitoneal (sacrospinous, iliococcygeal) | Prolapse Repair | 11.34 |
| 57283 | Colpopexy, vaginal intraperitoneal (uterosacral, levator myorrhaphy) | Prolapse Repair | 11.37 |
| 57284 | Paravaginal defect repair; open abdominal approach | Prolapse Repair | 13.97 |
| 57285 | Paravaginal defect repair; vaginal approach | Prolapse Repair | 11.31 |
| 57423 | Paravaginal defect repair; laparoscopic approach | Prolapse Repair | 15.68 |
| 57425 | Laparoscopic colpopexy (sacrocolpopexy) | Prolapse Repair | 16.60 |
| 57291 | Construction of artificial vagina; without graft | Vaginal Recon / GAS | 8.42 |
| 57292 | Construction of artificial vagina; with graft | Vaginal Recon / GAS | 13.66 |
| 57295 | Revision (including removal) of prosthetic vaginal graft; vaginal approach | Vaginal Recon / GAS | 7.62 |
| 57296 | Revision of prosthetic vaginal graft; abdominal approach | Vaginal Recon / GAS | 16.15 |
| 55970 | Intersex surgery; male to female | Vaginal Recon / GAS | Carrier priced |
| 55980 | Intersex surgery; female to male | Vaginal Recon / GAS | Carrier priced |
| 54300 | Plastic operation of penis for straightening of chordee (e.g., hypospadias) | Genital Recon | 10.92 |
| 54304 | Plastic operation on penis for correction of chordee or first stage of fistula repair | Genital Recon | 12.95 |
| 54308 | Urethroplasty for second-stage hypospadias repair; ≤3 cm | Genital Recon | 12.30 |
| 54312 | Urethroplasty for second-stage hypospadias repair; >3 cm | Genital Recon | 14.15 |
| 54316 | Urethroplasty with free skin graft from area other than genitalia | Genital Recon | 17.60 |
| 54318 | Urethroplasty for third stage hypospadias repair to release penis from scrotum | Genital Recon | 12.12 |
| 54322 | One-stage distal hypospadias repair with simple meatal advancement (e.g., MAGPI, V-flap) | Genital Recon | 13.63 |
| 54324 | One-stage distal hypospadias repair with urethroplasty by local skin flaps (e.g., flip-flap, prepucial flap) | Genital Recon | 17.11 |
| 54326 | One-stage distal hypospadias repair with urethroplasty by local skin flaps and mobilization of urethra | Genital Recon | 16.59 |
| 54328 | One-stage distal hypospadias repair with extensive chordee dissection and urethroplasty (local flaps, graft patch and/or island flap) | Genital Recon | 16.47 |
| 54332 | One-stage proximal penile or penoscrotal hypospadias repair | Genital Recon | 17.91 |
| 54336 | One-stage perineal hypospadias repair | Genital Recon | 21.08 |
| 54340 | Repair of hypospadias complication (fistula, stricture, diverticulum); simple | Genital Recon | 9.47 |
| 54344 | Repair of hypospadias complication; with mobilization and skin flaps | Genital Recon | 16.63 |
| 54348 | Repair of hypospadias complication; with extensive dissection and urethroplasty | Genital Recon | 17.86 |
| 54352 | Repair of hypospadias cripple requiring extensive dissection and urethroplasty with flap or free graft | Genital Recon | 25.48 |
| 54380 | Plastic operation on penis for epispadias distal to external sphincter | Genital Recon | 13.83 |
| 54385 | Plastic operation on penis for epispadias distal to external sphincter; with incontinence | Genital Recon | 16.15 |
| 54390 | Plastic operation on penis for epispadias with exstrophy of bladder | Genital Recon | 22.20 |
| 54420 | Corpora cavernosa-saphenous vein shunt (priapism) | Genital Recon | 12.08 |
| 54430 | Corpora cavernosa-corpus spongiosum shunt (priapism) | Genital Recon | 10.78 |
| 54435 | Corpora cavernosa-glans penis fistulization for priapism (e.g., Winter, Al-Ghorab-type distal shunt) | Genital Recon | 6.64 |
| 54437 | Repair of traumatic corporeal tear(s) (penile fracture) | Genital Recon | 11.21 |
| 54438 | Replantation, penis, complete amputation including urethral repair | Genital Recon | Not on CY2026 PFS |
| 54440 | Plastic operation of penis for injury | Genital Recon | Carrier priced |
| 54520 | Orchiectomy, simple (including subcapsular) | Genital Recon | 5.17 |
| 54690 | Laparoscopy, surgical; orchiectomy | Genital Recon | 11.41 |
| 55175 | Scrotoplasty; simple | Genital Recon | 5.72 |
| 55180 | Scrotoplasty; complicated | Genital Recon | 11.49 |
| 40818 | Excision of mucosa of vestibule of mouth as donor tissue (oral mucosa graft harvest) | Graft Harvest | 2.76 |
| 40819 | Excision of frenum, labial or buccal | Graft Harvest | 2.45 |
| 50845 | Cutaneous appendico-vesicostomy (Mitrofanoff-type catheterizable channel) | Bladder Recon / Diversion | 21.90 |
| 51550 | Cystectomy, partial; simple | Bladder Recon / Diversion | 16.80 |
| 51555 | Cystectomy, partial, complicated (e.g., post-radiation, previous surgery) | Bladder Recon / Diversion | 22.60 |
| 51565 | Cystectomy, partial, with reimplantation of ureter(s) into bladder | Bladder Recon / Diversion | 23.09 |
| 51570 | Cystectomy, complete (simple cystectomy, benign disease) | Bladder Recon / Diversion | 26.77 |
| 51575 | Cystectomy, complete, with bilateral pelvic lymphadenectomy | Bladder Recon / Diversion | 33.33 |
| 51580 | Cystectomy, complete, with ureterosigmoidostomy or ureterocutaneous transplantations | Bladder Recon / Diversion | 34.49 |
| 51585 | Cystectomy, complete, with ureterosigmoidostomy and bilateral pelvic lymphadenectomy | Bladder Recon / Diversion | 38.65 |
| 51590 | Cystectomy, complete, with ureteroileal conduit or sigmoid bladder, including bowel anastomosis | Bladder Recon / Diversion | 35.42 |
| 51595 | Cystectomy, complete, with ureteroileal conduit and bilateral pelvic lymphadenectomy | Bladder Recon / Diversion | 40.29 |
| 51596 | Cystectomy, complete, with continent diversion to native or substitute bladder | Bladder Recon / Diversion | 43.15 |
| 51960 | Enterocystoplasty, including bowel anastomosis (ileocystoplasty / sigmoid cystoplasty) | Bladder Recon / Diversion | 24.77 |
| 50820 | Ureteroileal conduit (ileal loop diversion); including bowel anastomosis | Bladder Recon / Diversion | 23.47 |
| 50825 | Continent diversion to abdominal wall (Kock pouch, Indiana pouch, etc.) | Bladder Recon / Diversion | 29.91 |
| 50830 | Urinary undiversion (e.g., taking down ileal conduit, ureterosigmoidostomy) | Bladder Recon / Diversion | 32.93 |
| 50840 | Replacement of all or part of ureter by intestine segment, including anastomosis | Bladder Recon / Diversion | 21.83 |
| 50860 | Ureterostomy, transplantation of ureter to skin | Bladder Recon / Diversion | 16.65 |
| 51980 | Cutaneous vesicostomy | Bladder Recon / Diversion | 12.26 |
| 50400 | Pyeloplasty, plastic operation on renal pelvis with or without ureter; simple | Upper Tract Recon | 20.74 |
| 50405 | Pyeloplasty; complicated (congenital kidney abnormality, secondary, calycoplasty) | Upper Tract Recon | 25.21 |
| 50544 | Laparoscopic pyeloplasty | Upper Tract Recon | 22.79 |
| 50760 | Ureteroureterostomy | Upper Tract Recon | 19.57 |
| 50770 | Transureteroureterostomy | Upper Tract Recon | 20.69 |
| 50780 | Ureteroneocystostomy; anastomosis of single ureter to bladder | Upper Tract Recon | 19.45 |
| 50782 | Ureteroneocystostomy; anastomosis of duplicated ureter to bladder | Upper Tract Recon | 19.17 |
| 50783 | Ureteroneocystostomy; with extensive ureteral tailoring | Upper Tract Recon | 20.18 |
| 50785 | Ureteroneocystostomy; with vesico-psoas hitch or bladder flap | Upper Tract Recon | 21.67 |
| 50800 | Ureteroenterostomy, direct anastomosis of ureter to intestine | Upper Tract Recon | 16.00 |
| 50810 | Ureterosigmoidostomy with creation of sigmoid bladder and anastomosis (Mainz II) | Upper Tract Recon | 22.04 |
| 50815 | Ureterocolonic conduit, including bowel anastomosis | Upper Tract Recon | 21.70 |
| 50650 | Ureterectomy, with bladder cuff (separate procedure) | Upper Tract Recon | 18.35 |
| 50722 | Ureterolysis for ovarian or iliac vein syndrome | Upper Tract Recon | 17.50 |
| 50725 | Ureterolysis with reduction of vena cava (retrocaval ureter) | Upper Tract Recon | 19.70 |
| 50727 | Revision of urinary-cutaneous anastomosis (any type urostomy) | Upper Tract Recon | 8.07 |
| 50728 | Revision of urinary-cutaneous anastomosis with repair of fascial defect and hernia | Upper Tract Recon | 11.88 |
| 52341 | Cystourethroscopy with treatment of ureteral stricture (balloon, laser, electrocautery, incision) | Upper Tract Recon | 5.22 |
| 52342 | Cystourethroscopy with treatment of ureteropelvic junction stricture | Upper Tract Recon | 5.70 |
| 52343 | Cystourethroscopy with treatment of intra-renal stricture | Upper Tract Recon | 6.39 |
| 52346 | Cystourethroscopy with treatment of UPJ stricture (Acucise endopyelotomy) | Upper Tract Recon | 8.37 |
| 64561 | Percutaneous implantation of neurostimulator electrode array; sacral nerve (transforaminal), imaging guidance included | Sacral Neuromodulation | 5.30 |
| 64581 | Open implantation of neurostimulator electrode array; sacral nerve (transforaminal) | Sacral Neuromodulation | 11.90 |
| 64585 | Revision or removal of peripheral neurostimulator electrode array | Sacral Neuromodulation | 2.06 |
| 64590 | Insertion or replacement of peripheral, sacral or gastric neurostimulator pulse generator or receiver (pocket creation and connection to electrode array) | Sacral Neuromodulation | 4.97 |
| 64595 | Revision or removal of peripheral, sacral or gastric neurostimulator pulse generator or receiver | Sacral Neuromodulation | 3.70 |
| 95970 | Electronic analysis of implanted neurostimulator pulse generator, without programming | Sacral Neuromodulation | 0.35 |
| 95971 | Electronic analysis of implanted neurostimulator, simple programming (1–3 parameters) | Sacral Neuromodulation | 0.78 |
| 95972 | Electronic analysis of implanted neurostimulator, complex programming (more than 3 parameters) | Sacral Neuromodulation | 0.80 |
| 52287 | Cystoscopy with injection(s) for chemodenervation of the bladder (onabotulinumtoxinA) | OAB / Botox / PTNS | 3.12 |
| 64566 | Posterior tibial neurostimulation, percutaneous needle electrode, single treatment, programming included (PTNS; 000 global) | OAB / Botox / PTNS | 0.59 |
| 0816T | Category III: open insertion/replacement of integrated tibial neurostimulation system, subcutaneous | OAB / Botox / PTNS | Carrier priced |
| 0817T | Category III: open insertion/replacement of integrated tibial neurostimulation system, subfascial | OAB / Botox / PTNS | Carrier priced |
| 0818T | Category III: revision or removal of integrated tibial neurostimulation system, subcutaneous | OAB / Botox / PTNS | Carrier priced |
| 0819T | Category III: revision or removal of integrated tibial neurostimulation system, subfascial | OAB / Botox / PTNS | Carrier priced |
| 0589T | Category III: electronic analysis of integrated tibial neurostimulator, simple programming | OAB / Botox / PTNS | Carrier priced |
| 0590T | Category III: electronic analysis of integrated tibial neurostimulator, complex programming | OAB / Botox / PTNS | Carrier priced |
| 99459 | Pelvic examination add-on to an office E/M (practice-expense only, no work RVU; nonfacility PE RVU 0.52) | Office E/M add-ons | 0.00 |
| G2211 | Visit complexity add-on to office E/M for longitudinal care of a serious or complex condition | Office E/M add-ons | 0.33 |
| 52000 | Cystourethroscopy (separate procedure) | Cystoscopy | 1.49 |
| 52001 | Cystourethroscopy with irrigation and evacuation of multiple obstructing clots | Cystoscopy | 5.30 |
| 52005 | Cystourethroscopy with ureteral catheterization, with or without irrigation/instillation/ureteropyelography | Cystoscopy | 2.31 |
| 52204 | Cystourethroscopy with biopsy(s) | Cystoscopy | 2.53 |
| 52214 | Cystourethroscopy with fulguration of trigone, bladder neck, prostatic fossa, urethra, periurethral glands | Cystoscopy | 3.41 |
| 52224 | Cystourethroscopy with fulguration or treatment of minor bladder lesion(s) <0.5 cm | Cystoscopy | 3.95 |
| 52240 | Cystourethroscopy with fulguration or treatment of large bladder tumor(s) | Cystoscopy | 7.31 |
| 52310 | Cystourethroscopy with removal of foreign body, calculus, or ureteral stent (simple) | Cystoscopy | 2.74 |
| 52315 | Cystourethroscopy with removal of foreign body, calculus, or ureteral stent; complicated | Cystoscopy | 5.07 |
| 51702 | Insertion of temporary indwelling bladder catheter; simple (e.g., Foley) | Cystoscopy | 0.49 |
| 51703 | Insertion of temporary indwelling bladder catheter; complicated (altered anatomy, fractured catheter) | Cystoscopy | 1.43 |
| 51045 | Cystotomy with insertion of ureteral catheter or stent | Cystoscopy | 7.61 |
| 51100 | Aspiration of bladder; by needle | Cystoscopy | 0.76 |
| 51102 | Aspiration of bladder; with insertion of suprapubic catheter | Cystoscopy | 2.63 |
| 52441 | Cystourethroscopy with insertion of permanent adjustable transprostatic implant (UroLift); single | BPH | 3.90 |
| 52442 | Cystourethroscopy with insertion of permanent adjustable transprostatic implant; each additional | BPH | 0.98 |
| 53854 | Transurethral destruction of prostate tissue; by radiofrequency-generated water vapor (Rezūm) | BPH | 5.78 |
| 52601 | TURP, complete (includes vasectomy, meatotomy, internal urethrotomy, urethral calibration) | BPH | 9.75 |
| 52630 | TURP, residual or regrowth of obstructive tissue | BPH | 6.39 |
| 52647 | Laser coagulation of prostate | BPH | Not on CY2026 PFS |
| 52648 | Laser vaporization of prostate (PVP) | BPH | 9.80 |
| 52649 | Laser enucleation of prostate (HoLEP) | BPH | 12.68 |
| 53850 | Transurethral microwave thermotherapy of prostate (TUMT) | BPH | 5.28 |
| 53852 | Transurethral needle ablation of prostate (TUNA) | BPH | 5.78 |
| 54600 | Reduction of torsion of testis, surgical, with or without fixation of contralateral testis | Trauma / Genital | 7.45 |
| 54620 | Fixation of contralateral testis (separate procedure) | Trauma / Genital | 5.08 |
| 54670 | Suture or repair of testicular injury | Trauma / Genital | 6.48 |
| 11004 | Debridement of skin/subq/muscle/fascia for necrotizing soft tissue infection; external genitalia and perineum | Trauma / Genital | 10.53 |
| 11005 | Debridement of NSTI; abdominal wall | Trauma / Genital | 13.88 |
| 11006 | Debridement of NSTI; external genitalia, perineum and abdominal wall | Trauma / Genital | 12.77 |
Check ICD-10-CM codes and descriptions against the CMS files effective on the date of service.[23]
| ICD-10 | Description | Notes | Condition |
|---|---|---|---|
| N39.3 | Stress incontinence (male) (female) | — | Incontinence |
| N39.41 | Urge incontinence | — | Incontinence |
| N39.42 | Incontinence without sensory awareness | — | Incontinence |
| N39.43 | Post-void dribbling | — | Incontinence |
| N39.44 | Nocturnal enuresis | — | Incontinence |
| N39.45 | Continuous leakage | May indicate fistula | Incontinence |
| N39.46 | Mixed incontinence | Stress + urge components | Incontinence |
| N39.490 | Overflow incontinence | — | Incontinence |
| N39.491 | Coital incontinence | — | Incontinence |
| N39.492 | Postural (urinary) incontinence | — | Incontinence |
| N39.498 | Other specified urinary incontinence | — | Incontinence |
| R32 | Unspecified urinary incontinence | — | Incontinence |
| T83.111A | Breakdown (mechanical) of implanted urinary sphincter, initial encounter | — | AUS Complications |
| T83.118A | Breakdown of other urinary devices and implants, initial encounter | — | AUS Complications |
| T83.121A | Displacement of implanted urinary sphincter, initial encounter | — | AUS Complications |
| T83.191A | Other mechanical complication of implanted urinary sphincter, initial encounter | — | AUS Complications |
| T83.591A | Infection and inflammatory reaction due to implanted urinary sphincter, initial encounter | — | AUS Complications |
| T83.598A | Infection due to other prosthetic device/implant in urinary system, initial encounter | — | AUS Complications |
| T83.71XA | Erosion of implanted mesh into organ or tissue (urinary), initial encounter | — | AUS Complications |
| T83.81XA | Embolism due to genitourinary prosthetic device, initial encounter | — | AUS Complications |
| T83.490A | Other mechanical complication of implanted penile prosthesis, initial encounter | — | IPP Complications |
| T83.491A | Breakdown of implanted penile prosthesis, initial encounter | — | IPP Complications |
| T83.492A | Displacement of implanted penile prosthesis, initial encounter | — | IPP Complications |
| T83.61XA | Infection and inflammatory reaction due to implanted penile prosthesis, initial encounter | — | IPP Complications |
| N52.01 | Erectile dysfunction due to arterial insufficiency | — | Erectile Dysfunction |
| N52.02 | Corporo-venous occlusive erectile dysfunction | — | Erectile Dysfunction |
| N52.03 | Combined arterial insufficiency and corporo-venous occlusive ED | — | Erectile Dysfunction |
| N52.1 | Erectile dysfunction due to diseases classified elsewhere | — | Erectile Dysfunction |
| N52.2 | Drug-induced erectile dysfunction | — | Erectile Dysfunction |
| N52.31 | Erectile dysfunction following radical prostatectomy | — | Erectile Dysfunction |
| N52.32 | Erectile dysfunction following radical cystectomy | — | Erectile Dysfunction |
| N52.33 | Erectile dysfunction following urethral surgery | — | Erectile Dysfunction |
| N52.34 | Erectile dysfunction following simple prostatectomy | — | Erectile Dysfunction |
| N52.35 | Erectile dysfunction following radiation therapy | — | Erectile Dysfunction |
| N52.36 | Erectile dysfunction following interstitial seed therapy | — | Erectile Dysfunction |
| N52.37 | Erectile dysfunction following prostate ablative therapy | — | Erectile Dysfunction |
| N52.39 | Other and unspecified postprocedural erectile dysfunction | — | Erectile Dysfunction |
| N52.8 | Other male erectile dysfunction | — | Erectile Dysfunction |
| N52.9 | Male erectile dysfunction, unspecified | — | Erectile Dysfunction |
| N48.6 | Induratio penis plastica (Peyronie's disease) | — | Peyronie's / Penile |
| N48.0 | Leukoplakia of penis (includes lichen sclerosus of penis) | — | Peyronie's / Penile |
| N48.1 | Balanoposthitis | — | Peyronie's / Penile |
| N48.2 | Other inflammatory disorders of penis | — | Peyronie's / Penile |
| N48.81 | Thrombosis of superficial vein of penis | — | Peyronie's / Penile |
| N48.82 | Acquired buried penis | — | Peyronie's / Penile |
| N48.83 | Sclerosing lymphangitis of penis | — | Peyronie's / Penile |
| N48.89 | Other specified disorders of penis | — | Peyronie's / Penile |
| N48.30 | Priapism, unspecified | — | Priapism |
| N48.31 | Priapism due to trauma | — | Priapism |
| N48.32 | Priapism due to disease classified elsewhere | — | Priapism |
| N48.33 | Priapism, drug-induced | — | Priapism |
| N48.39 | Other priapism | Ischemic, not elsewhere classified | Priapism |
| N35.010 | Post-traumatic urethral stricture, male, meatal | — | Urethral Stricture |
| N35.011 | Post-traumatic bulbous urethral stricture | — | Urethral Stricture |
| N35.012 | Post-traumatic membranous urethral stricture | — | Urethral Stricture |
| N35.013 | Post-traumatic anterior urethral stricture | — | Urethral Stricture |
| N35.014 | Post-traumatic urethral stricture, male, unspecified | — | Urethral Stricture |
| N35.016 | Post-traumatic urethral stricture, male, overlapping sites | Panurethral stricture | Urethral Stricture |
| N35.111 | Postinfective urethral stricture NEC, male, meatal | — | Urethral Stricture |
| N35.112 | Postinfective bulbous urethral stricture NEC | — | Urethral Stricture |
| N35.113 | Postinfective membranous urethral stricture NEC, male | — | Urethral Stricture |
| N35.114 | Postinfective anterior urethral stricture NEC, male | — | Urethral Stricture |
| N35.116 | Postinfective urethral stricture NEC, male, overlapping sites | Panurethral stricture | Urethral Stricture |
| N35.119 | Postinfective urethral stricture NEC, male, unspecified site | — | Urethral Stricture |
| N35.12 | Postinfective urethral stricture NEC, female | — | Urethral Stricture |
| N35.811 | Other urethral stricture, male, meatal | — | Urethral Stricture |
| N35.812 | Other urethral bulbous stricture, male | — | Urethral Stricture |
| N35.813 | Other urethral membranous stricture, male | — | Urethral Stricture |
| N35.814 | Other anterior urethral stricture, male | — | Urethral Stricture |
| N35.816 | Other urethral stricture, male, overlapping sites | Panurethral stricture | Urethral Stricture |
| N35.819 | Other urethral stricture, male, unspecified site | — | Urethral Stricture |
| N35.82 | Other urethral stricture, female | — | Urethral Stricture |
| N35.919 | Unspecified urethral stricture, male, unspecified site | — | Urethral Stricture |
| N35.92 | Unspecified urethral stricture, female | — | Urethral Stricture |
| N99.110 | Postprocedural urethral stricture, male, meatal | — | Urethral Stricture |
| N99.111 | Postprocedural bulbous urethral stricture | — | Urethral Stricture |
| N99.112 | Postprocedural membranous urethral stricture | — | Urethral Stricture |
| N99.113 | Postprocedural anterior bulbous urethral stricture | — | Urethral Stricture |
| N99.114 | Postprocedural anterior urethral stricture, male | — | Urethral Stricture |
| N99.115 | Postprocedural urethral stricture, male, unspecified | — | Urethral Stricture |
| N99.116 | Postprocedural urethral stricture, male, overlapping sites | — | Urethral Stricture |
| N99.12 | Postprocedural urethral stricture, female | — | Urethral Stricture |
| N32.0 | Bladder-neck obstruction (bladder neck contracture) | Use for primary BNC, post-TURP BNC | BNC / VUAS |
| N99.89 | Other postprocedural complications of GU system | Use for VUAS when no specific code applies | BNC / VUAS |
| N82.0 | Vesicovaginal fistula | — | Fistula |
| N82.1 | Other female urinary-genital tract fistulae | Includes ureterovaginal, urethrovaginal | Fistula |
| N82.2 | Fistula of vagina to small intestine | — | Fistula |
| N82.3 | Fistula of vagina to large intestine (rectovaginal fistula) | — | Fistula |
| N82.4 | Other female intestinal-genital tract fistulae | — | Fistula |
| N82.5 | Female genital tract-skin fistulae | — | Fistula |
| N82.8 | Other female genital tract fistulae | — | Fistula |
| N82.9 | Female genital tract fistula, unspecified | — | Fistula |
| N36.0 | Urethral fistula | — | Fistula |
| N32.1 | Vesicointestinal fistula | Vesicoenteric, vesicosigmoid, rectourethral male | Fistula |
| N32.2 | Vesical fistula, not elsewhere classified | — | Fistula |
| K63.2 | Fistula of intestine | Use with N36.0 for male rectourethral fistula | Fistula |
| N31.0 | Uninhibited neuropathic bladder, NEC | — | Neurogenic Bladder |
| N31.1 | Reflex neuropathic bladder, NEC | — | Neurogenic Bladder |
| N31.2 | Flaccid neuropathic bladder, NEC | — | Neurogenic Bladder |
| N31.8 | Other neuromuscular dysfunction of bladder | — | Neurogenic Bladder |
| N31.9 | Neuromuscular dysfunction of bladder, unspecified | — | Neurogenic Bladder |
| N81.0 | Urethrocele | — | Prolapse |
| N81.10 | Cystocele, unspecified | — | Prolapse |
| N81.11 | Cystocele, midline | — | Prolapse |
| N81.12 | Cystocele, lateral | Paravaginal defect | Prolapse |
| N81.2 | Incomplete uterovaginal prolapse | — | Prolapse |
| N81.3 | Complete uterovaginal prolapse | — | Prolapse |
| N81.4 | Uterovaginal prolapse, unspecified | — | Prolapse |
| N81.5 | Vaginal enterocele | — | Prolapse |
| N81.6 | Rectocele | — | Prolapse |
| N81.81 | Perineocele | — | Prolapse |
| N81.82 | Incompetence/disruption of pelvic floor muscles | — | Prolapse |
| N81.84 | Cervical stump prolapse | Post-supracervical hysterectomy | Prolapse |
| N81.85 | Cervicovaginal fistula | — | Prolapse |
| N81.89 | Other female genital prolapse | — | Prolapse |
| N99.3 | Prolapse of vaginal vault after hysterectomy | — | Prolapse |
| T83.711A | Erosion of implanted mesh into vagina, initial encounter | — | Mesh Complications |
| T83.712A | Erosion of implanted mesh to surrounding organ or tissue | — | Mesh Complications |
| T83.713A | Erosion of implanted urethral bulking agent | — | Mesh Complications |
| T83.718A | Erosion of other implanted mesh into organ or tissue | — | Mesh Complications |
| T83.721A | Exposure of implanted mesh into vagina, initial encounter | — | Mesh Complications |
| T83.722A | Exposure of implanted mesh into surrounding organ/tissue | — | Mesh Complications |
| T83.723A | Exposure of implanted urethral bulking agent | — | Mesh Complications |
| T83.728A | Exposure of other implanted mesh into organ or tissue | — | Mesh Complications |
| N32.81 | Overactive bladder | Primary OAB diagnosis | OAB / LUTS |
| N32.89 | Other specified disorders of bladder | Bladder pain syndrome | OAB / LUTS |
| R39.15 | Urgency of urination | — | OAB / LUTS |
| R35.0 | Frequency of micturition | — | OAB / LUTS |
| R35.1 | Nocturia | — | OAB / LUTS |
| R35.89 | Other polyuria | — | OAB / LUTS |
| R33.0 | Drug-induced urinary retention | — | Voiding Dysfunction |
| R33.8 | Other retention of urine | — | Voiding Dysfunction |
| R33.9 | Retention of urine, unspecified | — | Voiding Dysfunction |
| R39.11 | Hesitancy of micturition | — | Voiding Dysfunction |
| R39.12 | Poor urinary stream | — | Voiding Dysfunction |
| R39.13 | Splitting of urinary stream | — | Voiding Dysfunction |
| R39.14 | Feeling of incomplete bladder emptying | — | Voiding Dysfunction |
| R39.16 | Straining on urination | — | Voiding Dysfunction |
| R39.198 | Other difficulties with micturition | — | Voiding Dysfunction |
| N13.8 | Other obstructive and reflux uropathy | — | Voiding Dysfunction |
| N30.10 | Interstitial cystitis (chronic) without hematuria | — | Interstitial Cystitis |
| N30.11 | Interstitial cystitis (chronic) with hematuria | — | Interstitial Cystitis |
| N30.30 | Trigonitis without hematuria | — | Interstitial Cystitis |
| N30.31 | Trigonitis with hematuria | — | Interstitial Cystitis |
| R30.0 | Dysuria | — | Interstitial Cystitis |
| R30.9 | Painful micturition, unspecified | — | Interstitial Cystitis |
| R31.0 | Gross hematuria | — | Hematuria |
| R31.1 | Benign essential microscopic hematuria | — | Hematuria |
| R31.21 | Asymptomatic microscopic hematuria | — | Hematuria |
| R31.29 | Other microscopic hematuria | — | Hematuria |
| K62.3 | Rectal prolapse | — | Anorectal |
| K62.89 | Other specified diseases of rectum | — | Anorectal |
| R15.0 | Incomplete defecation | Obstructed defecation | Anorectal |
| R15.1 | Fecal smearing | — | Anorectal |
| R15.2 | Fecal urgency | — | Anorectal |
| R15.9 | Full incontinence of feces | — | Anorectal |
| N13.0 | Hydronephrosis with ureteropelvic junction obstruction | Primary UPJO | Upper Tract |
| N13.1 | Hydronephrosis with ureteral stricture, NEC | — | Upper Tract |
| N13.2 | Hydronephrosis with renal and ureteral calculous obstruction | — | Upper Tract |
| N13.30 | Unspecified hydronephrosis | — | Upper Tract |
| N13.39 | Other hydronephrosis | — | Upper Tract |
| N13.4 | Hydroureter | — | Upper Tract |
| N13.5 | Crossing vessel and stricture of ureter without hydronephrosis | — | Upper Tract |
| N13.6 | Pyonephrosis | — | Upper Tract |
| N13.70 | Vesicoureteral-reflux, unspecified | — | Upper Tract |
| N13.71 | Vesicoureteral-reflux without reflux nephropathy | — | Upper Tract |
| N13.721 | VUR with reflux nephropathy without hydroureter, unilateral | — | Upper Tract |
| N13.722 | VUR with reflux nephropathy without hydroureter, bilateral | — | Upper Tract |
| N13.731 | VUR with reflux nephropathy with hydroureter, unilateral | — | Upper Tract |
| N13.732 | VUR with reflux nephropathy with hydroureter, bilateral | — | Upper Tract |
| N28.81 | Hypertrophy of kidney | — | Upper Tract |
| N28.82 | Megaloureter | — | Upper Tract |
| N28.86 | Ureteritis cystica | — | Upper Tract |
| N28.89 | Other specified disorders of kidney and ureter | Use for retroperitoneal-fibrosis ureteric obstruction | Upper Tract |
| Q54.0 | Hypospadias, balanic (glanular) | — | Congenital / Pediatric |
| Q54.1 | Hypospadias, penile | — | Congenital / Pediatric |
| Q54.2 | Hypospadias, penoscrotal | — | Congenital / Pediatric |
| Q54.3 | Hypospadias, perineal | — | Congenital / Pediatric |
| Q54.4 | Congenital chordee | — | Congenital / Pediatric |
| Q54.8 | Other hypospadias | — | Congenital / Pediatric |
| Q54.9 | Hypospadias, unspecified | — | Congenital / Pediatric |
| Q64.0 | Epispadias | — | Congenital / Pediatric |
| Q64.10 | Bladder exstrophy, unspecified | — | Congenital / Pediatric |
| Q64.11 | Supravesical fissure of urinary bladder | — | Congenital / Pediatric |
| Q64.12 | Cloacal exstrophy of urinary bladder | — | Congenital / Pediatric |
| Q64.19 | Other exstrophy of urinary bladder | — | Congenital / Pediatric |
| Q64.2 | Congenital posterior urethral valves | — | Congenital / Pediatric |
| Q64.31 | Congenital bladder neck obstruction | — | Congenital / Pediatric |
| Q64.32 | Congenital stricture of urethra | — | Congenital / Pediatric |
| Q64.5 | Congenital absence of bladder and urethra | — | Congenital / Pediatric |
| Q64.6 | Congenital diverticulum of bladder | — | Congenital / Pediatric |
| Q64.71 | Congenital prolapse of urethra | — | Congenital / Pediatric |
| Q64.74 | Double urethra | — | Congenital / Pediatric |
| Q64.75 | Double urinary meatus | — | Congenital / Pediatric |
| Q43.7 | Persistent cloaca | — | Congenital / Pediatric |
| Q56.0 | Hermaphroditism, NEC | DSD spectrum | Congenital / Pediatric |
| Q56.1 | Male pseudohermaphroditism, NEC | — | Congenital / Pediatric |
| Q56.2 | Female pseudohermaphroditism, NEC | — | Congenital / Pediatric |
| Q56.3 | Pseudohermaphroditism, unspecified | — | Congenital / Pediatric |
| Q56.4 | Indeterminate sex, unspecified | — | Congenital / Pediatric |
| F64.0 | Transsexualism | — | Gender / GAS |
| F64.1 | Dual role transvestism | — | Gender / GAS |
| F64.2 | Gender identity disorder of childhood | — | Gender / GAS |
| F64.8 | Other gender identity disorders | — | Gender / GAS |
| F64.9 | Gender identity disorder, unspecified | — | Gender / GAS |
| Z87.890 | Personal history of sex reassignment | — | Gender / GAS |
| N89.5 | Stricture and atresia of vagina | Vaginal stenosis | Female Genital |
| N89.6 | Tight hymenal ring | — | Female Genital |
| N89.8 | Other specified noninflammatory disorders of vagina | — | Female Genital |
| N90.4 | Leukoplakia of vulva | — | Female Genital |
| N90.5 | Atrophy of vulva | — | Female Genital |
| N90.60 | Unspecified hypertrophy of vulva | — | Female Genital |
| N90.61 | Childhood asymmetric labium majus enlargement | — | Female Genital |
| N90.69 | Other specified hypertrophy of vulva | Labial hypertrophy | Female Genital |
| N94.10 | Unspecified dyspareunia | — | Female Genital |
| N94.11 | Superficial (introital) dyspareunia | — | Female Genital |
| N94.12 | Deep dyspareunia | — | Female Genital |
| N94.818 | Other vulvodynia | — | Female Genital |
| N95.2 | Postmenopausal atrophic vaginitis (GSM) | — | Female Genital |
| L90.0 | Lichen sclerosus et atrophicus | Penile/genital LS | Skin / LS |
| L73.2 | Hidradenitis suppurativa | — | Skin / LS |
| N40.0 | Benign prostatic hyperplasia without LUTS | — | BPH / Prostate |
| N40.1 | Benign prostatic hyperplasia with LUTS | — | BPH / Prostate |
| N40.2 | Nodular prostate without LUTS | — | BPH / Prostate |
| N40.3 | Nodular prostate with LUTS | — | BPH / Prostate |
| N42.81 | Prostatodynia syndrome | — | BPH / Prostate |
| N42.82 | Prostatosis syndrome | — | BPH / Prostate |
| N42.83 | Cyst of prostate | — | BPH / Prostate |
| S37.20XA | Unspecified injury of bladder, initial encounter | — | Trauma |
| S37.30XA | Unspecified injury of urethra, initial encounter | — | Trauma |
| S37.32XA | Laceration of urethra, initial encounter | — | Trauma |
| S39.840A | Fracture of corpus cavernosum penis, initial encounter | — | Trauma |
| S31.30XA | Unspecified open wound of penis, initial encounter | — | Trauma |
| N49.3 | Fournier gangrene | — | Trauma |
| C67.9 | Malignant neoplasm of bladder, unspecified | Use when cystectomy is for cancer | Bladder Recon Indication |
| D09.0 | Carcinoma in situ of bladder | — | Bladder Recon Indication |
| N32.83 | Detrusor hypertrophy | — | Bladder Recon Indication |
| F52.22 | Female sexual arousal disorder | — | Sexual Dysfunction |
| F52.31 | Female orgasmic disorder | — | Sexual Dysfunction |
| F52.6 | Dyspareunia not due to a substance or known physiological condition | — | Sexual Dysfunction |
| N94.819 | Vulvodynia, unspecified | — | Sexual Dysfunction |
| N39.0 | Urinary tract infection, site not specified | — | UTI |
| N30.00 | Acute cystitis without hematuria | — | UTI |
| N30.01 | Acute cystitis with hematuria | — | UTI |
| N30.20 | Other chronic cystitis without hematuria | — | UTI |
| N30.21 | Other chronic cystitis with hematuria | — | UTI |
| Z87.440 | Personal history of urinary (tract) infections | Recurrent UTI history | UTI |
Modifiers are appended to CPT codes to indicate special circumstances.
| Modifier | Name | When to Use |
|---|---|---|
| 22 | Increased Procedural Services | Document complexity beyond typical; specify additional time required |
| 25 | Significant, Separately Identifiable E/M | Same-day E/M beyond the usual pre- or post-procedure evaluation (for example a decision-making visit plus an office procedure). Append to the E/M code, never the procedure code, and document the E/M separately (AUGS Coding Committee 2025) |
| 50 | Bilateral Procedure | Procedure performed on both sides |
| 51 | Multiple Procedures | Two or more separate, non-bundled procedures in one session. For Medicare procedures subject to the standard multiple-surgery rule, the highest-valued code is paid at 100% and additional qualifying codes at 50% (AUGS Coding Committee 2026).[17] |
| 52 | Reduced Services | Procedure partially reduced or a component eliminated |
| 53 | Discontinued Procedure | Procedure stopped after anesthesia due to extenuating circumstances |
| 58 | Staged / Related Procedure | Planned staged procedure or more extensive follow-up in post-op period |
| 59 | Distinct Procedural Service | Bundling override for a truly distinct service (different session, site, organ, lesion or injury) when no more specific modifier applies. Not for E/M (use 25). Medicare asks for XE, XS, XP or XU when one fits. NCCI treats the pelvis as one region, so the note should name the separate pelvic-floor compartments |
| 62 | Co-Surgeon | Two primary surgeons performing distinct portions; each reports same CPT + 62 |
| 66 | Surgical Team | Highly complex surgery requiring multiple specialties simultaneously |
| 74 | Discontinued Outpatient / ASC Procedure | Procedure aborted after anesthesia started in outpatient or ASC setting |
| 76 | Repeat Procedure — Same Physician | Same CPT, same patient, same day |
| 77 | Repeat Procedure — Different Physician | Same CPT, same patient, same day, different surgeon |
| 78 | Unplanned Return to OR | Unplanned same-physician return to the operating room for a related procedure during the post-op global period[17] |
| 79 | Unrelated Procedure in Post-op Period | Unrelated to primary procedure's post-op global |
| 80 | Assistant Surgeon | Primary surgeon bills CPT alone; assistant bills CPT + 80 |
| 82 | Assistant Surgeon (No Qualified Resident) | Must justify. Primary uses CPT only; assistant uses CPT + 82 |
| AS | PA / NP / CNS Assistant at Surgery | Reports the assist when performed by a non-physician |
| XE | Separate Encounter | Service distinct because it occurred during a separate encounter |
| XS | Separate Structure | Service distinct because performed on a separate organ or structure |
| XP | Separate Practitioner | Service distinct because performed by a different practitioner |
| XU | Unusual Non-Overlapping Service | Service does not overlap usual components of the main service |
| LT / RT | Left / Right Side | Designate side for unilateral procedures on paired organs |
| Resource | Description | Link |
|---|---|---|
| AMA CPT Code Lookup | Official AMA CPT code database (subscription) | ama-assn.org |
| CMS Physician Fee Schedule | CMS fee schedule lookup with current wRVU values | cms.gov |
| AAPC Coder | Comprehensive ICD-10 and CPT lookup tool | aapc.com |
| ICD-10-CM Browser | Official CMS ICD-10 browser | icd10data.com |
| NCCI Edits | CMS National Correct Coding Initiative bundling edits | cms.gov/ncci |
| AUA Coding Guides | AUA coding and reimbursement resources for urologists | auanet.org |
| CMS Medicare Coverage Database | LCD and NCD coverage-policy lookup by contractor and jurisdiction | cms.gov |
| AUGS Coding Resources | Urogynecology-specific coding guidance | augs.org |
Coding and Coverage Notes (2025–2026)
Dated practice notes from the AUGS Coding Committee commentaries and CMS documents. Re-check each January and against the local payer.
- E/M with procedures. When a significant, separately identifiable same-day E/M service is billed with a procedure, append modifier 25 to the E/M code, never to the procedure.[17] A same-day procedure and E/M may require modifier 25, which generally prevents G2211 payment except with an eligible preventive service or vaccine administration; assess +99459 under its own add-on rules, so separating the visits is sometimes cleaner (Thompson 2025).[1][17] Inside a global period, use 99024 for related follow-up. Unrelated care during a global period takes modifier 24 (E/M) or 79 (procedure).[1]
- E/M level selection. Choose by medical decision-making or total time on the date of the visit. Prolonged-service code 99417 is added for each full 15 minutes beyond the highest code's minimum time (Davidson 2025).[2] Medicare does not accept 99417 (status I on the CY2026 file) and uses G2212, which has its own time thresholds.
- +99459 (pelvic examination). Practice-expense-only add-on to an office E/M, once per patient per day, nonfacility settings only. Document the indication and chaperone presence (Price and Mamik 2025).[3] Its RVUs are in the table above.
- G2211. Add-on for longitudinal care of a serious or complex condition, such as recurrent prolapse followed with a pessary. It generally cannot be reported when the same-day E/M carries modifier 25, except when an eligible preventive service or vaccine administration is also provided (Mamik and Price 2025).[4][17]
- Modifiers 51, 59 and 22. Prolapse repair plus midurethral sling reports 57240 with 57288-51. Cystoscopy (52000) is bundled with a sling and is not unbundled. Reserve modifier 22 for work substantially greater than typical, with the reason, added time and specific challenges in the operative note (Molden 2026).[5]
- Sacral neuromodulation. Code the electrode by approach: 64561 percutaneous (10-day global, imaging included) or 64581 open (90-day global; add 76000-26 for fluoroscopy interpretation). A peripheral nerve evaluation is 64561, with 95971 or 95972 when programmed. A replacement reports only the new lead and/or generator code (Muñoz and Davidson 2025).[6]
- Urodynamics. Bill the highest-valued complex code first (51726–51729); add 51741-51 for complex uroflowmetry only when separately performed on a separate machine and medically necessary, and 51784/51785-51 for EMG only when medically necessary. 51797 needs no modifier.[24] Post-void residual is bundled, and a simple cystometrogram is not combined with complex codes (Raza-Khan and Baker 2025).[7]
- Implantable tibial nerve stimulation. Category III codes carry no national RVUs, so payers may ask for a comparable Category I code. Obtain prior authorization and document diagnosis and prior treatments (Shah and Panza 2026).[8]
- Onabotulinumtoxin A coverage. LCD L35170, effective February 22, 2026, requires an objective OAB severity scale at baseline and at each follow-up, at least 12 weeks of standard treatment including behavioral and drug therapy, and 100 U for idiopathic OAB. Injections may not be repeated more often than every 12 weeks. These are local policies that other contractors may not have adopted (AUGS advisory; Hall 2026).[9][10]
- Budget neutrality. When CMS projects a payment change above $20 million, it offsets it through the conversion factor. Overestimated G2211 use cut the 2024 factor by 2.18% when actual use was about 11% of E/M office visits rather than the projected 38% (Hall 2026).[11]
Documentation for Office E/M Visits
Office and outpatient evaluation and management (E/M) visits, CPT 99202–99215, are leveled by one of two routes: the level of medical decision making (MDM) or the reporting clinician's total time on the date of the encounter. The AMA introduced this framework into CPT effective January 1, 2021,[12] and Medicare adopted it through the CY2020 and CY2021 Physician Fee Schedule final rules.[13][14] A medically appropriate history and examination are still documented, but their extent no longer determines the level.[12] Visits in a reconstructive or functional practice center on medication decisions and surgical counseling, so MDM is usually the route that captures the work, and time is the better route for long counseling visits with little data.[15]
New and Established Patients
CPT defines a new patient as one who has received no professional services within the past three years from the reporting clinician or from another clinician of the exact same specialty and subspecialty in the same group practice.[16] Medicare's manual uses the phrase "same physician specialty", and a test interpretation billed without a face-to-face service does not make the patient established.[17] An internal referral from a general urology partner to a reconstructive or FPMRS colleague in the same group is therefore a question for the billing office before the visit is coded as new.
Levels, MDM and Time
| Code | Patient | MDM level | Total time on the date (met or exceeded) | CY2026 wRVUs |
|---|---|---|---|---|
| 99202 | New | Straightforward | 15 min | 0.93 |
| 99203 | New | Low | 30 min | 1.60 |
| 99204 | New | Moderate | 45 min | 2.60 |
| 99205 | New | High | 60 min | 3.50 |
| 99211 | Established | Not applicable (may not require the physician) | Not applicable | 0.18 |
| 99212 | Established | Straightforward | 10 min | 0.70 |
| 99213 | Established | Low | 20 min | 1.30 |
| 99214 | Established | Moderate | 30 min | 1.92 |
| 99215 | Established | High | 40 min | 2.80 |
The 2021 descriptors gave time ranges (99212, for example, was 10–19 minutes). CPT 2024 removed the ranges, and each code now carries a single threshold that must be met or exceeded.[12][18] Times and wRVUs are from the CY2026 relative value file.[19]
MDM. MDM has three elements, and a level is reached when two of the three meet or exceed that level.[16] The table below condenses the CPT grid.
| MDM level | Problems addressed | Data reviewed and analyzed | Risk of management |
|---|---|---|---|
| Straightforward | One self-limited or minor problem | Minimal or none | Minimal |
| Low | Two or more minor problems, one stable chronic illness, or one acute uncomplicated illness | Limited: two category 1 items, or an independent historian | Low |
| Moderate | A chronic illness that is worsening, progressing or causing treatment side effects; two or more stable chronic illnesses; an undiagnosed new problem with uncertain prognosis; an acute illness with systemic symptoms | One of three categories: three category 1 items (an independent historian counts as one), an independent interpretation of a test, or a discussion of management with an external clinician | Moderate, for example prescription drug management, elective major surgery without identified risk factors, minor surgery with risk factors, or care significantly limited by social determinants of health |
| High | A chronic illness with severe exacerbation or side effects; an illness or injury that threatens life or bodily function | Two of the three categories | High, for example elective major surgery with patient or procedure risk factors, emergency major surgery, a decision about hospitalization, or drug therapy requiring intensive toxicity monitoring |
The CPT definitions decide most audits:[16]
- Addressed. A problem counts only when it is evaluated or treated at the encounter. A note that another clinician manages it, or a referral without evaluation, does not count.
- Stable. Stability is judged against the patient's own treatment goal. A chronic condition that is unchanged but not at goal is not stable.
- Category 1 items. Each unique test ordered or reviewed, and the notes from each unique external source, count once. Ordering a test includes review of its result, and repeated results of the same test count as one.
- Independent historian. A parent, guardian, spouse or other person gives history because the patient cannot give a complete or reliable one, or because confirmation is needed. Interpreter services do not count.
- Independent interpretation. The clinician interprets a test that has a CPT code and is not billed by that clinician, such as outside retrograde urethrogram or CT images, and records the reading.
- External discussion. An interactive exchange with a clinician outside the group or specialty, such as the referring urologist or radiation oncologist. Sending a note does not qualify.
- Separately billed services. A test or procedure whose professional component the same clinician reports, such as urodynamics or office cystoscopy, is not also counted as data.
Time. Total time includes the clinician's own work on the date of the encounter: preparing, reviewing outside records, examining, counseling, ordering, communicating with other clinicians, documenting and coordinating care. It excludes work normally done by clinical staff, travel and the time spent on any separately reported procedure.[16] Medicare requires the full time for the level (no midpoint rounding) and a record of total time or start and stop times.[20] Prolonged time begins at different points for the two prolonged codes. CPT 99417 is added once time exceeds the level 5 threshold by 15 minutes (75 minutes with 99205, 55 minutes with 99215).[16] Medicare's G2212 starts at 89 minutes with 99205 and 69 minutes with 99215, with a further unit for each additional 15 minutes.[17][20]
Worked Examples
These examples apply the CPT grid;[16] the clinical details are illustrative.
New patient with post-prostatectomy incontinence considering an AUS. A man referred two years after radical prostatectomy uses four pads a day despite pelvic floor therapy. The urologist reviews the referring urologist's notes and the hospital's operative and pathology reports (two unique external sources) and the latest PSA (one test), examines him, performs office cystoscopy, and counsels him on a male sling and an AUS; he chooses the AUS.
- Problems: moderate. Incontinence that is not at the patient's goal is a chronic illness with treatment side effects, not a stable one.
- Data: moderate. Three category 1 items. The cystoscopy is billed as 52000 and adds nothing to data.
- Risk: moderate for a decision about elective major surgery without risk factors; high if the note names patient or procedure risk factors such as prior pelvic radiation or anticoagulation.
- Result: moderate MDM, 99204 with modifier 25, plus 52000. High risk alone does not reach 99205. If the urologist also personally reads the outside urethrogram images and records the interpretation, data become extensive (two categories), and extensive data with high risk support 99205.
- By time, 45 minutes of the urologist's own work on the date, excluding the cystoscopy, also supports 99204.
Established patient with recurrent UTI on prophylaxis. A postmenopausal woman returns on nightly prophylaxis and vaginal estrogen.
- Breakthrough infections: she has had two culture-proven infections since the last visit. The urologist reviews the outside cultures (one unique test) and orders renal and bladder ultrasound (a second test), for limited data. The problem is a chronic illness that is progressing on treatment (moderate), and the prophylactic regimen is changed, which is prescription drug management (moderate). Two elements at moderate support 99214 even though data are only limited. A bladder-scan residual billed as 51798 is not also counted as data.
- At goal: she has had no infections in six months. The urologist reviews one surveillance culture and a creatinine ordered by her primary care physician (two unique tests, limited data) for one stable chronic illness (low). Two elements at low support 99213.
- When the urologist is the continuing focal point for this condition, G2211 may also apply, subject to the same-day procedure restriction in the coding notes above.[4]
Documentation Pitfalls
- Cloned notes. Copy-forward text and templates raise questions of authorship, accuracy and medical necessity, and institutions and payers have written policies on copied and imported EHR text.[21] The note should show what was addressed at this visit. Medicare's improper-payment program lists established office visits among the three leading E/M error categories, with errors from insufficient documentation, medical necessity and incorrect coding.[22]
- Unsupported time. A generic time attestation does not show that the time was the clinician's, was on the date of service, and excluded the procedure. State the total minutes and what they covered.[16][20]
- Uncredited data. Data the clinician used but did not name earn no credit. The note should name each external source and test, the historian and why the historian was needed, a one-line independent interpretation, and whom the plan was discussed with.[16]
- Unrecorded status and options. The problem's status against goal decides between stable and progressing. Management options considered and declined after shared decision making count toward risk only when the note records them.[16]
- Listed but not addressed. Comorbidities copied into the assessment without evaluation or treatment do not add problems.[16]
Same-Day Procedures, Modifier 25 and Global Periods
Modifier 25 goes on the E/M code when the E/M is significant and separately identifiable, above the usual pre- and postprocedure work of a same-day procedure; different diagnoses are not required, but both services must be documented (see the Modifiers tab).[16][17] A practical test is whether the E/M portion, written up on its own, would stand as a billable visit, and whether it covers a different problem or work beyond the procedure.[15] Evaluating a new SUI referral and deciding on an AUS, then performing cystoscopy the same day, meets that test. A return visit booked for a planned office cystoscopy or bladder onabotulinumtoxinA injection, with no new problem, does not: for minor procedures, Medicare treats the decision made immediately beforehand as routine preoperative work.[17]
For a procedure with a 90-day global, an E/M on the day of or the day before surgery that results in the initial decision to operate takes modifier 57 rather than 25; an example is an inpatient consultation for an infected penile prosthesis that leads to explantation the same day. Modifier 57 is not used for 0-day or 10-day procedures.[17]
The global package covers related preoperative visits from the day before a major (090) procedure or the day of a minor (000 or 010) procedure, the operation, complications not requiring a return to the operating room, and related postoperative visits (reported as 99024).[17] In the CY2026 file, office cystoscopy (52000), bladder chemodenervation (52287) and urethral bulking (51715) carry 0-day globals; percutaneous sacral lead placement (64561) and Peyronie's plaque injection (54200) carry 10-day globals; AUS (53445), three-piece IPP (54405), sling (57288), anterior urethroplasty (53410) and open sacral lead placement (64581) carry 90-day globals.[19] A visit inside a global for an unrelated problem, such as a new erectile dysfunction evaluation at the six-week AUS activation visit, is reported with modifier 24 and documented as unrelated.[15][17]
Operative Notes
Coders assign procedure codes from two parts of the operative note. The procedures-performed list names every separately reportable procedure, and some surgeons add the CPT code and any modifier with its supporting statement. The narrative describes each procedure in its own labeled part, so that a combined case such as a sling with prolapse repair can be matched line by line to its codes. Reporting component codes when a comprehensive code exists is unbundling, which is denied and creates compliance exposure.[15]
Estimating Clinic wRVUs
Under wRVU-based compensation, clinic output can be estimated from the visit and procedure mix. Twenty established visits split evenly between 99213 and 99214 generate about 32 wRVUs (10 × 1.30 plus 10 × 1.92); each same-day office cystoscopy adds 1.49, and the E/M is added only when modifier 25 is supported.[19] Category III and carrier-priced codes, such as implantable tibial nerve stimulation, have no national work RVU, so any wRVU credit for them under an employment contract is set by the employer and is worth settling before the service line starts. The RVU components, conversion factor and payment models are covered in Healthcare Finance & Payment Models.
References
1. Thompson CD. Tips for office procedural coding. Urogynecology (Phila). 2025;31(10):911–912. doi:10.1097/SPV.0000000000001747
2. Davidson ERW. Evaluation and management (E/M) coding. Urogynecology (Phila). 2025;31(12):1085–1086. doi:10.1097/SPV.0000000000001717
3. Price JR, Mamik MM. CPT code +99459: it's worth understanding. Urogynecology (Phila). 2025;31(2):86–87. doi:10.1097/SPV.0000000000001649
4. Mamik MM, Price JR. G2211 coding guidance in urogynecology. Urogynecology (Phila). 2025;31(6):557–558. doi:10.1097/SPV.0000000000001689
5. Molden S. Choosing between surgical modifiers -51, -59, and -22: practical urogynecology examples. Urogynecology (Phila). 2026;32(8):897–899. doi:10.1097/SPV.0000000000001861
6. Muñoz JM, Davidson ERW. Coding for sacral neuromodulation. Urogynecology (Phila). 2025;31(11):999–1000. doi:10.1097/SPV.0000000000001758
7. Raza-Khan F, Baker M. Coding for urodynamic procedures. Urogynecology (Phila). 2025;31(9):825–826. doi:10.1097/SPV.0000000000001728
8. Shah NM, Panza J. Use of T codes for implantable tibial nerve stimulation. Urogynecology (Phila). 2026;32(9):1019–1020. doi:10.1097/SPV.0000000000001876
9. American Urogynecologic Society. Practice advisory: CMS LCD L35170, onabotulinumtoxinA (Botox), effective February 22, 2026. AUGS; 2026.
10. Hall EF. CMS Botox coverage updates: key requirements for urologic use. Urogynecology (Phila). 2026;32(7):771–772. doi:10.1097/SPV.0000000000001882
11. Hall EF. Budget neutrality, physician reality: how CMS budget rules affect physicians. Urogynecology (Phila). 2026;32(5):475–476. doi:10.1097/SPV.0000000000001827
12. American Medical Association. CPT Evaluation and Management (E/M) Office or Other Outpatient (99202–99215) and Prolonged Services (99354, 99355, 99356, 99417) Code and Guideline Changes, effective January 1, 2021 (with technical corrections of March 9, 2021). Chicago, IL: AMA; 2021. ama-assn.org
13. Centers for Medicare & Medicaid Services. Medicare program; CY 2020 revisions to payment policies under the Physician Fee Schedule and other changes to Part B payment policies. Final rule. Fed Regist. 2019;84:62568. November 15, 2019. govinfo.gov
14. Centers for Medicare & Medicaid Services. Medicare program; CY 2021 payment policies under the Physician Fee Schedule and other changes to Part B payment policies. Final rule. Fed Regist. 2020;85:84472. December 28, 2020. govinfo.gov
15. AUA Young Urologists Committee. Transitioning from Residency to Practice Manual. 8th ed. Linthicum, MD: American Urological Association; 2025.
16. American Medical Association. CPT Evaluation and Management (E/M) Code and Guideline Changes, effective January 1, 2023. Chicago, IL: AMA; 2022. ama-assn.org
17. Centers for Medicare & Medicaid Services. Medicare Claims Processing Manual, Chapter 12: Physicians/Nonphysician Practitioners, sections 30.6.6, 30.6.7, 30.6.15.2 and 40.1–40.2. Rev. 13316; July 24, 2025. cms.gov
18. American Medical Association. AMA releases the CPT 2024 code set [press release]. September 8, 2023. ama-assn.org
19. Centers for Medicare & Medicaid Services. Physician Fee Schedule relative value file RVU26C (July 2026 release). cms.gov
20. Centers for Medicare & Medicaid Services. Evaluation and Management Services. MLN Booklet MLN006764. May 2026. cms.gov
21. Weis JM, Levy PC. Copy, paste, and cloned notes in electronic health records: prevalence, benefits, risks, and best practice recommendations. Chest. 2014;145(3):632–638. doi:10.1378/chest.13-0886
22. Centers for Medicare & Medicaid Services. Complying with Medical Record Documentation Requirements. MLN Fact Sheet MLN909160. October 2024. cms.gov
23. Centers for Medicare & Medicaid Services. ICD-10-CM Code Files. cms.gov (accessed October 2026).
24. American Medical Association. September 2022 AMA/Specialty Society RVS Update Committee Meeting Minutes. ama-assn.org